Search results
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey.
We produce essential medicines. Our broad portfolio is the foundation from which we make healthy possible. In the US, our portfolio of more than 270 medicines provides patients with more affordable access to quality medicines.
Our retail and institutional portfolio contains more than 260+ generic medicines, many of which represent difficult-to-manufacture products or products that have a high barrier-to-entry such as oncologics, anti-infectives and supportive care to healthcare providers.
About. AboutWe challenge convention so healthy can be possible. Our Story. Amneal at-a-glance. Our Founders. Our Milestones. Our Purpose & Commitments. Our Culture. Rise, Lead, Succeed.
Get the latest Amneal Pharmaceuticals Inc (AMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
May 16, 2023 · May 16, 2023. - Third of three approved U.S. oncology biosimilars Amneal has launched. BRIDGEWATER, N.J.-- (BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the commercial launch of FYLNETRA™ (pegfilgrastim-pbbk), a biosimilar referencing Neulasta ® in a pre-filled single-dose ...
Nov 22, 2022 · Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals, primarily within the United States.
